Anika Therapeutics
ANIK
ANIK
163 hedge funds and large institutions have $529M invested in Anika Therapeutics in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 58 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $1.06M | Put options by funds: $1.8M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
163
Holding in Top 10
1
Calls
$1.06M
Puts
$1.8M
Top Buyers
| 1 | +$7.09M | |
| 2 | +$4.46M | |
| 3 | +$3.81M | |
| 4 |
Goldman Sachs
New York
|
+$2.76M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.09M |
Top Sellers
| 1 | -$10M | |
| 2 | -$5.7M | |
| 3 | -$4.38M | |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$4.1M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.94M |